Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase 2 (COX-2), is the rate-limiting enzyme in the biosynthesis of prostaglandin (PG) and capable of metabolizing arachidonic acid to the precursor prostaglandin H2 (PGH2). COX-2 plays a crucial role during early pregnancy, including ovulation, fertilization, implantation and metaphase. COX is active in PD pathogenesis by indirectly affecting a cell's decision to undergo apoptosis, and inhibition of COX can provide relief from inflammatory and pain symptoms. Several studies have shown that inflammatory proteins are also targets of COX-2. Selective inhibition of COX-2 induced by pro-inflammatory cytokines at the inflammation site can increase the anti-inflammatory properties. One of the advantages of targeting COX-2 is its usual specific localization in inflamed tissues. In addition, selective inhibition of PTGS2 (COX-2) has showed fewer side effects than inhibition of the COX-1 enzyme.
BOC Sciences has developed a library to provide potential small-molecule inhibitors of PTGS2 (COX-2).
Figure 1. Schematic presentation of the action of cyclooxygenases (COX-1 and COX-2). (Konturek, P. C.; et al. 2005)
At BOC Sciences, our experts have established a high-throughput virtual screening method based on molecular docking approach to generate this library:
Figure 2. Different mechanisms by which COX-2 derived prostaglandins are involved in the carcinogenesis. (Konturek, P. C.; et al. 2005)
BOC Sciences provides professional, rapid and high-quality services of Prostaglandin-endoperoxide Synthase 2, Cyclooxygenase-2 (COX-2) Inhibitors Library design at competitive prices for global customers. Personalized and customized services of Prostaglandin-endoperoxide Synthase 2, Cyclooxygenase-2 (COX-2) Inhibitors Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.